{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T03:18:58Z","timestamp":1752549538557,"version":"3.37.3"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,7,10]],"date-time":"2021-07-10T00:00:00Z","timestamp":1625875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,7,10]],"date-time":"2021-07-10T00:00:00Z","timestamp":1625875200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1007\/s00198-021-06056-5","type":"journal-article","created":{"date-parts":[[2021,7,10]],"date-time":"2021-07-10T13:02:56Z","timestamp":1625922176000},"page":"309-312","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Primary hyperphosphatemic tumoral calcinosis: a case report"],"prefix":"10.1007","volume":"33","author":[{"given":"J.","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.-G.","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.-R.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2264-4443","authenticated-orcid":false,"given":"S.-M.","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Q.-Q.","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,7,10]]},"reference":[{"key":"6056_CR1","first-page":"725","volume":"74","author":"MH Duret","year":"1899","unstructured":"Duret MH (1899) Tumours multiples et singulieres des bourses sereuses (endotheliomes, peutetre d\u2019origine parasitaire). Bull Mem Soc Anat Paris 74:725\u2013733","journal-title":"Bull Mem Soc Anat Paris"},{"key":"6056_CR2","unstructured":"Teutschlaender OJBPA (1949) Die lipoido-calcinosis oder lipoidkalkgicht. 110:402-432"},{"key":"6056_CR3","first-page":"490","volume":"121","author":"A INCLAN","year":"1943","unstructured":"INCLAN A, Leon P, MGJJotAMA C (1943) Tumoral calcinosis 121:490\u2013495","journal-title":"Tumoral calcinosis"},{"key":"6056_CR4","doi-asserted-by":"crossref","unstructured":"Smack DP, Norton SA, Fitzpatrick J E (1996) Proposal for a pathogenesis-based classification of tumoral calcinosis. 35:265-271","DOI":"10.1111\/j.1365-4362.1996.tb02999.x"},{"key":"6056_CR5","doi-asserted-by":"publisher","first-page":"293","DOI":"10.3389\/fendo.2020.00293","volume":"11","author":"AM Boyce","year":"2020","unstructured":"Boyce AM, Lee AE, Roszko KL, Gafni RI (2020) Hyperphosphatemic tumoral calcinosis: pathogenesis, clinical presentation, and challenges in management. Front Endocrinol (Lausanne) 11:293","journal-title":"Front Endocrinol (Lausanne)"},{"key":"6056_CR6","doi-asserted-by":"crossref","unstructured":"Harkess JW, Peters HJJJ (1967) Tumoral calcinosis: a report of six cases. 49:721-731","DOI":"10.2106\/00004623-196749040-00014"},{"key":"6056_CR7","doi-asserted-by":"crossref","unstructured":"Pakasa N, Kalengayi RJH (1997) Tumoral calcinosis: a clinicopathological study of 111 cases with emphasis on the earliest changes. 31:18-24","DOI":"10.1046\/j.1365-2559.1997.6050831.x"},{"key":"6056_CR8","doi-asserted-by":"crossref","unstructured":"Olsen KM, Chew FSJR (2006) Tumoral calcinosis: pearls, polemics, and alternative possibilities. 26:871-885","DOI":"10.1148\/rg.263055099"},{"key":"6056_CR9","doi-asserted-by":"crossref","unstructured":"Savaci N, Avunduk MC, Tosun Z, Hosnuter MJP, Surgery R (2000) Hyperphosphatemic tumoral calcinosis. 105:162-165","DOI":"10.1097\/00006534-200001000-00027"},{"key":"6056_CR10","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1086\/508069","volume":"79","author":"O Topaz","year":"2006","unstructured":"Topaz O, Indelman M, Chefetz I et al (2006) A deleterious mutation in SAMD9 causes normophosphatemic familial tumoral calcinosis. Am J Hum Genet 79:759\u2013764","journal-title":"Am J Hum Genet"},{"key":"6056_CR11","doi-asserted-by":"crossref","unstructured":"Chefetz I, Amitai DB, Browning S, Skorecki K, Adir N, Thomas MG, Kogleck L, Topaz O, Indelman M, Uitto J (2008) Normophosphatemic familial tumoral calcinosis is caused by deleterious mutations in SAMD9, encoding a TNF-\u03b1 responsive protein. 128:1423-1429","DOI":"10.1038\/sj.jid.5701203"},{"key":"6056_CR12","doi-asserted-by":"crossref","unstructured":"Ramnitz MS, Gourh P, Goldbach-Mansky R, et al. (2016) Phenotypic and genotypic characterization and treatment of a cohort with familial tumoral calcinosis\/hyperostosis-hyperphosphatemia syndrome. 31:1845-1854","DOI":"10.1002\/jbmr.2870"},{"key":"6056_CR13","doi-asserted-by":"publisher","first-page":"R23","DOI":"10.1530\/JME-20-0178","volume":"66","author":"BB Ho","year":"2021","unstructured":"Ho BB, Bergwitz C (2021) FGF23 signalling and physiology. J Mol Endocrinol 66:R23\u2013R32","journal-title":"J Mol Endocrinol"},{"key":"6056_CR14","doi-asserted-by":"crossref","unstructured":"Garringer HJ, Corinne F, Larsson TE, et al. (2006) The role of mutant UDP-N-acetyl-alpha-D-galactosamine-polypeptide N-acetylgalactosaminyltransferase 3 in regulating serum intact fibroblast growth factor 23 and matrix extracellular phosphoglycoprotein in heritable tumoral calcinosis. 4037","DOI":"10.1210\/jc.2006-0305"},{"key":"6056_CR15","doi-asserted-by":"crossref","unstructured":"Urakawa I, Yamazaki Y, Shimada T, Iijima K, Hasegawa H, Okawa K, Fujita T, Fukumoto S, Yamashita TJN (2006) Klotho converts canonical FGF receptor into a specific receptor for FGF23. 444:770","DOI":"10.1038\/nature05315"},{"key":"6056_CR16","doi-asserted-by":"crossref","unstructured":"Chakhtoura M, Ramnitz MS, Khoury N, Nemer G, Fuleihan G E H (2018) Hyperphosphatemic familial tumoral calcinosis secondary to fibroblast growth factor 23 (FGF23) mutation: a report of two affected families and review of the literature. 29:1987-2009","DOI":"10.1007\/s00198-018-4574-x"},{"key":"6056_CR17","doi-asserted-by":"crossref","unstructured":"Steinbach LS, Johnston JO, Tepper EF, Honda GD, Martel W (1995) Tumoral calcinosis: radiologic-pathologic correlation. %J Skeletal Radiology. 24:573-578","DOI":"10.1007\/BF00204854"},{"key":"6056_CR18","doi-asserted-by":"crossref","unstructured":"Tomori Y, Nanno M, Takai SJM (2020) Acute calcific periarthritis of the proximal phalangeal joint on the fifth finger: a case report and literature review. 99:","DOI":"10.1097\/MD.0000000000021477"},{"key":"6056_CR19","doi-asserted-by":"crossref","unstructured":"Bravo VD, Liuzza F, Perisano C, Chalidis B, Marzetti E, Colelli P, Maccauro GJHItJoC, Pathology ERoH, Therapy (2012) Gluteal tumoral calcinosis. 22:585","DOI":"10.5301\/HIP.2012.10347"},{"key":"6056_CR20","doi-asserted-by":"crossref","unstructured":"Aydin A, Tuncer S, Erer M, Bilgic BJ (2004) Tumoral calcinosis infiltrating the biceps brachii tendon \u2013 excision and reconstruction with allograft: a case report. 29:170-172","DOI":"10.1016\/j.jhsb.2003.11.001"},{"key":"6056_CR21","doi-asserted-by":"crossref","unstructured":"Yamaguchi T, Sugimoto T, Imai Y, Fukase M, Fujita T, Chihara KJB (1995) Successful treatment of hyperphosphatemic tumoral calcinosis with long-term acetazolamide. 16:247S","DOI":"10.1016\/S8756-3282(95)80001-8"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-021-06056-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00198-021-06056-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-021-06056-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,13]],"date-time":"2022-01-13T14:11:45Z","timestamp":1642083105000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00198-021-06056-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,10]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["6056"],"URL":"https:\/\/doi.org\/10.1007\/s00198-021-06056-5","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"type":"print","value":"0937-941X"},{"type":"electronic","value":"1433-2965"}],"subject":[],"published":{"date-parts":[[2021,7,10]]},"assertion":[{"value":"1 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"None.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}